Navigation Links
Lupus Foundation of America Seeks Funding Proposals for Research Studies on Childhood Lupus, Nervous System Involvement, and More
Date:4/17/2008

WASHINGTON, April 17 /PRNewswire-USNewswire/ -- The Lupus Foundation of America (LFA) is seeking proposals for up to $1.5 million in grant funding for basic, clinical, or translational research studies on lupus, an unpredictable and potentially fatal autoimmune disease. The purposes of the studies are to: accelerate ongoing research; directly sponsor novel approaches; and develop experimental prototypes. Grants will support four areas of study: childhood, or pediatric, lupus; neuropsychiatric lupus; adult stem cells; and novel pilot projects.

As part of this request for proposals, the LFA announces its new Michael Jon Barlin Pediatric Lupus Program. There is a special urgency associated with research on pediatric lupus. Early and aggressive treatment can have a dramatic, positive impact on disease activity and on the later progression of disease. Therefore, new diagnostic and prognostic tests, as well as treatments specifically for children, are more important than ever in addressing this potentially devastating form of lupus.

Also new this year is grant funding for neuropsychiatric lupus that affects the central nervous system and the brain. These dangerous symptoms occur in 50-91 percent of those with lupus, and can be a major source of illness, severely diminished quality of life, and death. Of special importance are tools to measure disease activity and damage, and a better understanding of risk factors, disease course, and effective treatment of specific neuropsychiatric symptoms.

Binding letters of intent must be submitted by April 21, 2008. Online applications must be submitted by May 19, 2008. Awards will be announced on July 11, 2008. For additional information, visit the research section of the LFA Website at lupus.org.

The LFA is the nation's foremost nonprofit voluntary health organization dedicated to finding the causes of and cure for lupus, and providing support, services, and hope to all people affected by lupus. The LFA and its network of nearly 300 chapters, branches, and support groups conduct programs of research, education, and advocacy.

The LFA research program is supported exclusively through donations from the LFA's constituent chapters, private foundations or corporations, and the concerned public, including The Cooper Family Foundation and the Louis Berkowitz Family Foundation.

Lupus is the result of a defective immune system which can be destructive to any organ of the body. Lupus can be unpredictable and potentially fatal, yet no satisfactory treatment or cure exists. More than 1.5 million Americans and at least five million people worldwide have a form of lupus.


'/>"/>
SOURCE Lupus Foundation of America
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Preclinical study suggests organ-transplant drug may aid in lupus fight
2. Genes Boost Risk for Rheumatoid Arthritis, Lupus
3. The Will and Jada Smith Family Foundation and Maybelline Join Forces With the Lupus Foundation of America for a Star-studded Gala to Raise Awareness for Lupus
4. Better Lupus Treatments on the Horizon
5. Stars Shine on Butterflies Over Hollywood for Lupus Foundation of America
6. Clinical Trials for Lupus Underway After Decades of Drought
7. October is Lupus Awareness Month
8. New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs
9. Photo: New York Goes Orange for Pumpkin Festival and Lupus Awareness Month
10. Mayo Clinic shows therapy effective for reducing lupus flares
11. Research suggests targeted treatment strategies for lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... 2017 , ... Support of value-based care models requires collaboration across all facets ... industry solutions, Fogo Data Centers announces the launch of the Fogo Partner Community™. , ... one in which all systems work well, work together, and work together well. ...
(Date:2/21/2017)... (PRWEB) , ... February 21, ... ... of technology-enabled clinical trial solutions, today announced the further expansion of its ... applications they can leverage as part of Bioclinica’s extensive and growing eHealth ...
(Date:2/21/2017)... ... February 21, 2017 , ... Atlanta-based Jvion, ... analytic firm Predixion’s Healthcare IT practice. Predixion, which raised $42M+ to date, received ... giants including Accenture, GE Ventures, and Software AG , will bring top ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... chronically untreated despite the medical, mental health, and financial consequences of inaction. On ... to take action if they have concerns about their hearing. , Effective treatment ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... protein espresso drinks, announced its products are now available for purchase on RonnieColemanNutrition.com, ... Drink Mix has become popular among health-conscious consumers who love coffee but are ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... 21, 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Liver Cirrhosis Drugs Price Analysis and Strategies ... Cirrhosis market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Liver Cirrhosis ...
(Date:2/21/2017)... and Markets has announced the addition of the "Rosacea Drugs Price ... ... Analysis and Strategies - 2016, provides drug pricing data and benchmarks in ... What are the key drugs marketed for Rosacea ... market? What are the unit prices and annual treatment ...
(Date:2/21/2017)... Research and Markets has announced the addition of ... to their offering. ... latest research Anthrax Drugs Price Analysis and Strategies - 2016, provides drug ... research answers the following questions: What are the ... positioned in the Global Anthrax market? What are the ...
Breaking Medicine Technology: